Barclays PLC grew its holdings in Ambarella, Inc. (NASDAQ:AMBA – Free Report) by 281.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 388,090 shares of the semiconductor company’s stock after purchasing an additional 286,296 shares during the period. Barclays PLC owned about 0.94% of Ambarella worth $21,891,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Meeder Asset Management Inc. purchased a new stake in shares of Ambarella in the second quarter valued at approximately $26,000. Blue Trust Inc. grew its position in shares of Ambarella by 180.3% during the 3rd quarter. Blue Trust Inc. now owns 499 shares of the semiconductor company’s stock worth $27,000 after buying an additional 321 shares in the last quarter. CWM LLC increased its stake in shares of Ambarella by 127.7% during the second quarter. CWM LLC now owns 542 shares of the semiconductor company’s stock valued at $29,000 after buying an additional 304 shares during the period. Signaturefd LLC raised its holdings in shares of Ambarella by 389.6% in the third quarter. Signaturefd LLC now owns 661 shares of the semiconductor company’s stock valued at $37,000 after acquiring an additional 526 shares in the last quarter. Finally, Larson Financial Group LLC lifted its stake in Ambarella by 6,014.3% in the third quarter. Larson Financial Group LLC now owns 856 shares of the semiconductor company’s stock worth $48,000 after acquiring an additional 842 shares during the period. 82.09% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, COO Chan W. Lee sold 1,490 shares of Ambarella stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $53.54, for a total transaction of $79,774.60. Following the completion of the sale, the chief operating officer now directly owns 121,406 shares in the company, valued at approximately $6,500,077.24. The trade was a 1.21 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Feng-Ming Wang sold 4,301 shares of the business’s stock in a transaction on Tuesday, September 17th. The shares were sold at an average price of $53.54, for a total transaction of $230,275.54. Following the sale, the chief executive officer now directly owns 799,527 shares in the company, valued at $42,806,675.58. This trade represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,474 shares of company stock valued at $1,246,694. 5.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Report on Ambarella
Ambarella Price Performance
Shares of AMBA stock opened at $72.53 on Friday. The stock’s fifty day moving average price is $62.53 and its 200 day moving average price is $56.95. Ambarella, Inc. has a 1-year low of $39.69 and a 1-year high of $81.32. The company has a market cap of $3.02 billion, a price-to-earnings ratio of -18.79 and a beta of 1.68.
Ambarella Profile
Ambarella, Inc develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image signal processing, and artificial intelligence processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.
Featured Articles
- Five stocks we like better than Ambarella
- With Risk Tolerance, One Size Does Not Fit All
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Earnings Reports?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Ambarella Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambarella and related companies with MarketBeat.com's FREE daily email newsletter.